Delivery Order SPE2DB22D1017-SPE2DB24FF8GW
Award Date 5/23/24
Potential Completion Date 5/24/24
Potential Value $4.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENBREL 25 MG/0.5 ML SYRINGE 0.5ML. The firm-fixed-price delivery order, valued at $4,178.14, has a completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) has awarded a Delivery Order contract, valued at $57,321.41, to Amerisourcebergen Drug Corporation's Corporate Office division. This contract is for the supply of ENBREL 50 MG/ML syringes, with an ultimate completion date of April 22, 2024. The contract is a Firm Fixed Price arrangement, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award is for the delivery of ENBREL 50 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The $7,006.87 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of April 3, 2025 and was not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award is for the delivery of ENBREL 50 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $95,114.82 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of January 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, involves the delivery of ENBREL 50 MG/ML SYRINGEML to the U.S. Department of Defense (DoD) via the Defense Logistics Agency (DLA) Troop Support Medical. The $10,349.88 firm fixed price delivery order has a performance period through March 28, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,836.33 fixed-price delivery order contract is for the supply of ENBREL 50 MG/ML syringes. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,152.14 firm fixed price delivery order is for Enbrel 50 mg/mL syringes and has a completion date of May 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the delivery of ENBREL 50 MG/ML syringes to the Defense Logistics Agency (DLA). The contract, valued at $11,098.88, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 21, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,788.77 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division. The contract has a completion date of July 31, 2024 and is not set aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,136.36 firm fixed-price delivery order is for the supply of Enbrel 50 mg/mL syringes. The contract has an ultimate completion date of November 22, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...